A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Personalis, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 15,103 shares of PSNL stock, worth $59,354. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,103
Previous 10,599 42.49%
Holding current value
$59,354
Previous $12,000 575.0%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$1.19 - $6.34 $5,359 - $28,555
4,504 Added 42.49%
15,103 $81,000
Q2 2024

Jul 29, 2024

BUY
$1.17 - $1.65 $12,400 - $17,488
10,599 New
10,599 $12,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $180M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.